Neuropharmacology of the essential oil of bergamot
Giacinto Bagetta1, Luigi Antonio Morrone, Laura Rombolà
1Department of Pharmacobiology and University Centre for Adaptive Disorders and Headache, Section of Neuropharmacology of Normal and Pathological Neuronal Plasticity, University of Calabria, Arcavacata di Rende, CS, Italy. g_bagetta@virgilio.it
Abstract:
Bergamot (Citrus bergamia, Risso) is a fruit most knowledgeable for its essential oil (BEO) used in aromatherapy to minimize symptoms of stress-induced anxiety and mild mood disorders and cancer pain though the rational basis for such applications awaits to be discovered. The behavioural and EEG spectrum power effects of BEO correlate well with its exocytotic and carrier-mediated release of discrete amino acids endowed with neurotransmitter function in the mammalian hippocampus supporting the deduction that BEO is able to interfere with normal and pathological synaptic plasticity. The observed neuroprotection in the course of experimental brain ischemia and pain does support this view. In conclusion, the data yielded so far contribute to our understanding of the mode of action of this phytocomplex on nerve tissue under normal and pathological experimental conditions and provide a rational basis for the practical use of BEO in complementary medicine. The opening of a wide venue for future research and translation into clinical settings is also envisaged.
Related Concept Videos
Physiology of Smell and Olfactory Pathway
The olfactory...
Drugs Affecting Neurotransmitter Release or Uptake
Olfaction
The olfactory receptors are embedded in the cilia of the...
Drugs Affecting Neurotransmitter Synthesis
Olfactory Receptors: Location and Structure
Neurochemical Transmission: Sites of Drug Action


